AI Blood Test Can Predict Heart Disease 15 Years Before Symptoms Appear

Introducing CardiOmicScore: A New AI-Powered Blood Analysis System

According to НВ — Техно: The University of Hong Kong (HKUMed) has unveiled CardiOmicScore, an innovative blood analysis system driven by artificial intelligence. This tool examines 2,920 circulating proteins and 168 metabolites to evaluate the risk of developing six cardiovascular conditions, which include:

• coronary artery disease
• stroke
• heart failure
• atrial fibrillation
• peripheral artery disease
• venous thromboembolism

CardiOmicScore can detect warning signals up to 15 years before a disease becomes clinically apparent, potentially transforming how cardiovascular diseases are prevented.

Research and Public Health Impact

The development of CardiOmicScore is grounded in research using data from the UK Biobank. The study employs multi-omics approaches, including genomics, proteomics, and metabolomics. According to the World Health Organization, approximately 19.8 million people died from cardiovascular diseases in 2022, underscoring the critical need for early detection and prevention strategies.

Accuracy improves when patient details like age and sex are added to the analysis. Professor Zhang Qingpeng, an associate professor in pharmacology and pharmacy at HKU, explains:

'Our genes set our starting point-they determine our baseline health risk. But proteins and metabolites reveal our current physical condition. Our AI tool is built to decode these complex molecular signals, enabling doctors and patients to spot risks much earlier. This could change the course of the disease through timely lifestyle adjustments and early preventive care.'

This new tool opens up possibilities for early diagnosis of cardiovascular disease, giving healthcare providers powerful risk assessment capabilities. Given the high global death toll from heart-related conditions, innovations like CardiOmicScore may play a decisive role in improving population health and reducing mortality rates.

The adoption of CardiOmicScore could significantly reshape healthcare by allowing doctors to create personalized prevention and treatment plans based on early risk detection. As cardiovascular disease remains one of the world's leading causes of death, such technologies represent a major step toward enhancing quality of life and overall public health.

In addition to innovative blood analysis, advancements in heart disease diagnostics are also being made with technologies like the heart diagnostic patch developed by the University of Chicago. This patch boasts an impressive accuracy rate of 99.6%, further enhancing the tools available for early detection of cardiovascular issues. To learn more about this groundbreaking technology, visit the details on the heart diagnostic patch.